Skip to content

MAZE MAZE Market capitalization

Market capitalization at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$113.44B-8.9%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.08B+319%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.93B+436%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$1.3B+406%
Zymeworks logo
ZymeworksZYME
$1.86B+125%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.64B+40.1%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Computed from the period-end share price: $1.47B.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's market capitalization?
MAZE (MAZE) reported market capitalization of $1.47B in Q1 2026.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.